Gastrointestinal stromal tumour--a paradigm shift in management of solid tumours.
Article
em En
| IMSEAR
| ID: sea-86078
Gastrointestinal stromal tumour (GIST) till recently were non-responsive to all chemotherapy agents. With the advent of c-kit, diagnosis of GIST has become more specific. STI-571, a tyrosine kinase, has become one of the first targeted therapeutic agent tobe active in solid tumour. At present it is the only agent with substantial activity in GIST.
Texto completo:
1
Índice:
IMSEAR
Assunto principal:
Piperazinas
/
Pirimidinas
/
Proteínas Tirosina Quinases
/
Humanos
/
Imuno-Histoquímica
/
Marcadores Genéticos
/
Radioterapia Adjuvante
/
Proteínas Proto-Oncogênicas c-kit
/
Embolização Terapêutica
/
Inibidores Enzimáticos
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article